UNH Roars Ahead on Scale and High ROIC

UnitedHealth Group's stock price has surged to $400.22 per share after delivering solid quarterly results, outperforming the S&P 500 by a significant margin of 25.4% over the past six months.

The company's ability to negotiate with suppliers due to economies of scale is one reason behind its success. With revenue exceeding $450.1 billion in the last year, UnitedHealth operates as one of the largest enterprises in healthcare, a sector where volume-driven businesses thrive.

Another key attribute is its stellar Return on Invested Capital (ROIC), which stands at 19.2% over the past five years, surpassing other healthcare companies by a considerable margin. This indicates UnitedHealth's management team has effectively invested in growth opportunities and generated substantial returns for shareholders.

However, there is also a reason to be cautious: UnitedHealth's ROIC has declined recently, suggesting its new investments may not yield the desired results. Only time will tell if these bets can pay off and reverse this trend.